Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.35
+0.05 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
11.39
+0.04 (0.35%)
After-hours: Mar 9, 2026, 5:26 PM EDT

Keros Therapeutics Employees

Keros Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 91 or -53.85% compared to the previous year.

Employees
78
Change (1Y)
-91
Growth (1Y)
-53.85%
Revenue / Employee
$3,128,987
Profits / Employee
$1,115,564
Market Cap
223.79M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202578-91-53.85%
Dec 31, 20241693324.26%
Dec 31, 20231363129.52%
Dec 31, 20221054575.00%
Dec 31, 2021602571.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
Humacyte 220
Protalix BioTherapeutics 213
Voyager Therapeutics 172
Cibus 159
MediWound 111
Alector 103
Camp4 Therapeutics 55
Sol-Gel Technologies 34
Employee Rankings

KROS News

More News